Clinical Research Site

Chicago, Illinois 60640

5 studies enrolling now · 12 studies all time

What they study most

Depression, Essential Hypertension, Excessive Sleepiness, Fibromyalgia, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Schizophrenia, Shift-work Disorder, Treatment Resistant Depression

Studies at this site

• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) — Stopped early
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia — Stopped early
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
• Mechanistic Evaluation of Response in TRD (MERIT) — Completed
• An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension — Completed